DDX53 and leukemia: All possible antigenic epitopes of the TAA will be presented instead of some selected epitopes.[80] This strategy was applied to acute myeloid leukemia; it resulted in the induction of leukemia‐specific cytotoxic T lymphocytes and the identification of B1‐1 peptide as a novel immunogenic tumor‐associated antigen.[81] Mice with CT26 tumors were immunized with DCs co‐transfected with GM‐CSF mRNA and CT26 whole tumor mRNA; the cytotoxic activity of immunized mice was significantly higher than that of the control group.[64] Mu et al.